779 related articles for article (PubMed ID: 17457312)
1. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
Müller N; Schwarz MJ
Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
[TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
Müller N
Curr Opin Investig Drugs; 2010 Jan; 11(1):31-42. PubMed ID: 20047157
[TBL] [Abstract][Full Text] [Related]
3. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
4. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
Miura H; Ozaki N; Sawada M; Isobe K; Ohta T; Nagatsu T
Stress; 2008 May; 11(3):198-209. PubMed ID: 18465467
[TBL] [Abstract][Full Text] [Related]
5. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
6. [New developments on the serotonin hypothesis of depression: shunt of tryptophan].
Marazziti D; Baroni S; Picchetti M; Piccinni A; Silvestri S; Dell'Osso L
Riv Psichiatr; 2013; 48(1):23-34. PubMed ID: 23438698
[TBL] [Abstract][Full Text] [Related]
7. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.
Wichers MC; Maes M
J Psychiatry Neurosci; 2004 Jan; 29(1):11-7. PubMed ID: 14719046
[TBL] [Abstract][Full Text] [Related]
8. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
Oxenkrug GF
Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
[TBL] [Abstract][Full Text] [Related]
9. [Immunological aspects of depressive disorders].
Müller N; Schwarz MJ
Nervenarzt; 2007 Nov; 78(11):1261-73. PubMed ID: 17928982
[TBL] [Abstract][Full Text] [Related]
10. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
Myint AM; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
[TBL] [Abstract][Full Text] [Related]
11. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis.
Ramírez LA; Pérez-Padilla EA; García-Oscos F; Salgado H; Atzori M; Pineda JC
Biomedica; 2018 Sep; 38(3):437-450. PubMed ID: 30335249
[TBL] [Abstract][Full Text] [Related]
12. Immunology of major depression.
Müller N
Neuroimmunomodulation; 2014; 21(2-3):123-30. PubMed ID: 24557045
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42: implications for the pathogenesis of Alzheimer's disease.
Yamada A; Akimoto H; Kagawa S; Guillemin GJ; Takikawa O
J Neurochem; 2009 Aug; 110(3):791-800. PubMed ID: 19457071
[TBL] [Abstract][Full Text] [Related]
14. Monitoring tryptophan metabolism in chronic immune activation.
Schröcksnadel K; Wirleitner B; Winkler C; Fuchs D
Clin Chim Acta; 2006 Feb; 364(1-2):82-90. PubMed ID: 16139256
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices.
Hochstrasser T; Ullrich C; Sperner-Unterweger B; Humpel C
Neuroscience; 2011 Jun; 184():128-38. PubMed ID: 21501664
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism.
Oxenkrug GF
Ann N Y Acad Sci; 2010 Jun; 1199():1-14. PubMed ID: 20633104
[TBL] [Abstract][Full Text] [Related]
17. Association between increased tryptophan degradation and depression in cancer patients.
Kurz K; Schroecksnadel S; Weiss G; Fuchs D
Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):49-56. PubMed ID: 21076293
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.
Muller N; Schwarz M
Neurotox Res; 2006 Oct; 10(2):131-48. PubMed ID: 17062375
[TBL] [Abstract][Full Text] [Related]
19. Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders.
Müller N; Schwarz MJ
Expert Rev Neurother; 2006 Jul; 6(7):1017-38. PubMed ID: 16831116
[TBL] [Abstract][Full Text] [Related]
20. HPA and immune axes in stress: involvement of the serotonergic system.
Leonard BE
Neuroimmunomodulation; 2006; 13(5-6):268-76. PubMed ID: 17709948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
